Evidence map›Paper›PMID 40881557›Full record

ArticleCureus2025

Clinical and Metabolic Effects of Incretin-Based Pharmacotherapy in Normal-Weight Patients With Type 2 Diabetes: A Real-World Analysis.

Erin Carson, Fatima Khaleq, Cassidy McDonald, Nadine Smith, Alanis Rodriguez Colon

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Erin CarsonPharmacy Practice, University of Illinois at Chicago, Rockford, USA.
Fatima KhaleqPharmacy Department, University of Wisconsin, Madison, USA.
Cassidy McDonaldPharmacy Department, University of Wisconsin, Madison, USA.
Nadine SmithPharmacy Practice, University of Illinois at Chicago, Rockford, USA.
Alanis Rodriguez ColonPharmacy Practice, University of Illinois at Chicago, Rockford, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose To evaluate the impact of incretin-based pharmacotherapy on clinical outcomes in normal to underweight patients with type 2 diabetes mellitus in a real-world setting. Methods Patients with a body mass index less than 25 kg/m

Indexed as

diabetes type 2glp1-raglucagon-like peptide-1 receptor agonistshemoglobin a1c (hba1c)normal weightweight reduction

Identifiers

PMID40881557
PMCPMC12382426

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.